Moreover, KSQ‐4279 was also validated to potentiate the antitumor ability of doxorubicin (a substrate drug for multiple ABC transporters) in primary culture of tumor specimens obtained from drug‐refractory lung cancer patients ex vivo (Figure 2K–M). The gene discussed is ABCG2; the disease is lung cancer.